HighTower Advisors
IDXX icon

HighTower Advisors’s Idexx Laboratories IDXX Stock Holding History

HighTower Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$1K – 2358
2018
Q4 		$1K Hold
300
– – ﹤0.01% 2187
2018
Q3 		$1K Buy
+300
New +$72.8K ﹤0.01% 2263

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HighTower Advisors's IDXX Position: Q2 2026 in Review

HighTower Advisors reduced its Idexx Laboratories (IDXX) stake by 0.39% in Q2 2026, selling an estimated $62.3K and leaving 28,415 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #762.

HighTower Advisors first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.5M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • HighTower Advisors held 28,415 shares of Idexx Laboratories worth $15M as of Q2 2026.
  • HighTower Advisors sold 111 Idexx Laboratories shares in Q2 2026, an estimated $62.3K.
  • Idexx Laboratories made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #762 holding.
  • HighTower Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Idexx Laboratories position peaked at $24.5M in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.